lorem ipsum
Get the case study
Cofactor partnered with Curebase in a study looking to observe the effectiveness of oncology indication technology used to predict tumor response to certain treatments like immunotherapy. This ongoing study needed to collect tumor biopsy samples in oncology clinics where qualified patients were likely to be. To do this Curebase implemented a flexible study model that activated several local oncology clinics allowing the Sponsor to collect data in real-world settings by bringing this oncology diagnostic study to where qualified patients were
